A review of the changes to the licensing of influenza vaccines in Europe.
about
Single radial haemolysis compared to haemagglutinin inhibition and microneutralization as a correlate of protection against influenza A H3N2 in children and adolescents.Rapid assessment of the reactogenicity of a 2016-2017 seasonal influenza vaccine: results from a feasibility study.The challenge of vaccine policy-making with imperfect data.Age and Influenza-Specific Pre-Vaccination Antibodies Strongly Affect Influenza Vaccine Responses in the Icelandic Population whereas Disease and Medication Have Small Effects.Influenza vaccines: Evaluation of the safety profile.Negative Effect of Age, but Not of Latent Cytomegalovirus Infection on the Antibody Response to a Novel Influenza Vaccine Strain in Healthy Adults.Vienna Vaccine Safety Initiative.Immunogenicity and Safety of the New Inactivated Quadrivalent Influenza Vaccine Vaxigrip Tetra: Preliminary Results in Children ≥6 Months and Older Adults.Announcing the Publication of a WHO Guide to the Design and Interpretation of Observational Influenza Vaccine Effectiveness Studies.The adjuvant GLA-AF enhances human intradermal vaccine responsesAugmented CD4 T-cell and humoral responses after repeated annual influenza vaccination with the same vaccine component A/H1N1pdm09 over 5 yearsRole of Egg-adaptation Mutations in Low Influenza A(H3N2) Vaccine Effectiveness During the 2012-2013 Season
P2860
Q38951673-6206A0C8-B134-4618-972D-075A42974C01Q39157024-6E720467-0BF7-4055-9D7C-A43B695DD47FQ46144181-AD977615-E7E6-4019-BB11-0C8BE5A9B157Q47550139-598BDB5D-9E86-4F72-86BF-06D30F430EF4Q49345779-144833BF-60E5-4C2B-BC37-9AC9996978DDQ49587964-7B7FCC70-EFAA-4A3F-8777-24DD31B0DFF0Q50071052-EB16C836-A167-4E67-8BD3-8D2E006DA62FQ50420352-CF76AB08-809D-4DF9-806B-2566A3D8A294Q55346139-74BBBE26-55B9-4409-831D-C5C7370573FFQ57093670-693F4E2A-5560-47FD-BBA8-6EDF27DD2E7AQ57093922-C40BE379-FCEF-48C4-BC01-A4CD147A1323Q57462327-1B755B00-606D-4290-A13B-66722BE5540D
P2860
A review of the changes to the licensing of influenza vaccines in Europe.
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
A review of the changes to the licensing of influenza vaccines in Europe.
@ast
A review of the changes to the licensing of influenza vaccines in Europe.
@en
type
label
A review of the changes to the licensing of influenza vaccines in Europe.
@ast
A review of the changes to the licensing of influenza vaccines in Europe.
@en
prefLabel
A review of the changes to the licensing of influenza vaccines in Europe.
@ast
A review of the changes to the licensing of influenza vaccines in Europe.
@en
P2860
P356
P1476
A review of the changes to the licensing of influenza vaccines in Europe.
@en
P2093
Bettie Voordouw
Leonoor Wijnans
P2860
P356
10.1111/IRV.12351
P577
2015-10-06T00:00:00Z